|
Report Date : |
17.09.2014 |
IDENTIFICATION DETAILS
|
Name : |
SALEHIYA TRADING
ESTABLISHMENT |
|
|
|
|
Registered Office : |
Salehiya
Building, Abdullah Suleiman Al Hamdan Street, Sulaimaniyah District, P O Box
991, Riyadh 11421 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2013 |
|
|
|
|
Date of Incorporation : |
31.10.1978 |
|
|
|
|
Com. Reg. No.: |
1010004810, |
|
|
|
|
Legal Form : |
Sole
Proprietorship |
|
|
|
|
Line of Business : |
Wholesalers and retailers of pharmaceutical products, health care systems, medical equipment and laboratory equipment, hospital supplies, medicines, vitamins, antibiotics, surgical dressings, syringes and dental equipment, as well as health foods and clinical products. |
|
|
|
|
No of Employees : |
1,200 |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 01, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
|
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
|
Source
: CIA |
Company Name : SALEHIYA TRADING ESTABLISHMENT
Country of Origin : Saudi
Arabia
Legal Form :
Sole Proprietorship
Registration Date : 31st
October 1978
Commercial
Registration Number :
1010004810, Riyadh
Membership Number : 1240
Invested Capital :
SR 12,000,000
Total Workforce : 1,200
Activities :
Wholesalers and retailers of pharmaceutical products, health care systems, medical equipment and laboratory
equipment, hospital supplies, medicines, vitamins, antibiotics, surgical
dressings, syringes and dental equipment, as well as health foods and clinical
products.
Financial Condition : Good
Payments :
Nothing detrimental uncovered
Person Interviewed : Othman Jaber,
Finance Manager
SALEHIYA TRADING
ESTABLISHMENT
Building : Salehiya Building
Street : Abdullah Suleiman Al Hamdan
Street
Area : Sulaimaniyah District
PO Box : 991
Town : Riyadh 11421
Country : Saudi Arabia
Telephone : (966-11) 4646955 / 4633172 /
4633205
Facsimile : (966-11) 4634362
Email : genmail@salehiya.com
Subject operates
from a large suite of offices that are rented and located in the Central
Business Area of Riyadh.
Branch Offices
Location Distribution
· Bataweel Building, Ground Floor Showroom and pharmacy premises
Airport Road
Alamria
PO Box: 3869
Jeddah 21481
Tel: (966-12) 6436518 / 6733755
· Hospital Road Showroom and pharmacy premises
Tobaishi Area
PO Box: 399
Dammam 31411
Tel: (966-13) 8260830 / 8290096
Fax: (966-13) 8266371 / 8260017
·
PO Box:
1182 Showroom
and pharmacy premises
Khamis Mushait
Tel: (966-17) 2360856
Fax: (966-17) 2360856
·
PO Box:
5209 Showroom
and pharmacy premises
Qassim
Tel: (966-16) 3854479
Fax: (966-16) 3828722
·
PO Box:
2537 Showroom
and pharmacy premises
Madinah
Tel: (966-14) 8424315
Fax: (966-14) 8422071
Name Position
·
Sultan
Mohamed Bin Saleh Bin Sultan Proprietor
·
Dr Saud
Al Ishawie General
Manager
·
Mazen
Fatafata Commercial
Manager
·
Othman
Jaber Finance
Manager
Date of Establishment : 31st
October 1978
Legal Form :
Sole Proprietorship
Commercial Reg. No. : 1010004810,
Riyadh
Membership No. : 1240
Invested Capital
: SR 12,000,000
Sultan Mohamed Bin
Saleh Bin Sultan is the sole proprietor of the business.
Activities: Engaged
in the wholesale and retail of pharmaceutical products, health care systems,
medical equipment and laboratory equipment, hospital supplies, medicines,
vitamins, antibiotics, surgical dressings, syringes and dental equipment, as
well as health foods and clinical products.
Subject is also engaged in hospital management and operation, as well as the installation and maintenance of hospital equipment and laboratory apparatus.
Import
Countries : Worldwide
International
Suppliers :
·
MicroLink United
Kingdom
·
Keymed United
Kingdom
·
Chromagar France
·
ATC
Medical Technics GmbH Germany
·
Amgen United
States of America
·
Advanced
Pharmaceutical Industries Jordan
·
Astellas
Pharma Inc Japan
·
Bristol
Myers Squibb United
States of America
·
Croma Austria
·
Dar Al
Dawa Group Jordan
·
Ego
Pharmaceuticals Australia
·
GNP Egypt
·
Lek Am
Pharmaceuticals Poland
·
Meda Sweden
·
Medis Tunisia
·
Medac Germany
·
Novo
Nordisk Denmark
·
Venus
Remedies India
·
Norbrook
Laboratories United
Kingdom
·
Sanovet Austria
·
Acutronic Switzerland
·
BTL
Medical Technologies Czech
Republic
·
Colussi Italy
·
Covidien United States of America
·
Dimeda Germany
·
Enraf
Nonius
·
Eschmann United
Kingdom
·
Mindray China
·
Innomed Hungary
·
Sibelmed Spain
·
3M United
States of America
·
Helmer United
States of America
·
Leica Germany
·
Beurer Germany
·
Nubenco United
States of America
·
Phabel
Paris France
·
Stratpharma Switzerland
·
Unomedical United
States of America
·
Weigao China
Operating Trend : Steady
Subject has a
workforce of approximately 1,200 employees.
Financial
highlights provided by local sources are given below:
Currency: Saudi
Riyals (SR)
Year Ending 31/12/12: Year Ending 31/12/13:
Total Sales SR 1,635,000,000 SR 1,780,000,000
Local sources
consider subject’s financial condition to be Good.
The above figures
were provided by Mr Othman Jaber, Finance Manager
·
Riyad
Bank
King Abdul Aziz Road
PO Box: 22622
Riyadh 11416
Tel: (966-11) 4013030
·
Saudi
American Bank
Malaz Branch
PO
Box: 3388
Riyadh 11471
Tel: (966-11) 4774770
·
National
Commercial Bank
Malaz Branch
PO Box: 42536
Tel: (966-11) 4776450
Fax: (966-11) 4769502
·
Arab
National Bank (ANB)
King Faisal Street
PO Box: 56921
Riyadh 11564
Tel: (966-11) 4029000
Fax: (966-11) 4027747
No complaints
regarding subject’s payments have been reported.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the company
is considered to be a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.60.99 |
|
UK Pound |
1 |
Rs.99.10 |
|
Euro |
1 |
Rs.79.03 |
INFORMATION DETAILS
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.